Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacokinetics of enantiomers of chiral non-steroidal anti-inflammatory drugs.

Literature DB >> 3294019

Pharmacokinetics of enantiomers of chiral non-steroidal anti-inflammatory drugs.

F Jamali¹.

Abstract

Mesh：

Substances：

Year: 1988 PMID： 3294019 DOI： 10.1007/BF03189920

Source DB: PubMed Journal: Eur J Drug Metab Pharmacokinet ISSN： 0378-7966 Impact factor: 2.441

× No keyword cloud information.

35 in total

1. Inversion of optical configuration of alpha-methylfluorene-2-acetic acid (cicloprofen) in rats and monkeys.

Authors: S J Lan; K J Kripalani; A V Dean; P Egli; L T Difazio; E C Schreiber
Journal: Drug Metab Dispos Date: 1976 Jul-Aug Impact factor: 3.922

2. Stereoselective gas chromatographic analysis of etodolac enantiomers in human plasma and urine.

Authors: N N Singh; F Jamali; F M Pasutto; R T Coutts; A S Russell
Journal: J Chromatogr Date: 1986-10-31

Review 3. Interrelationships between xenobiotic metabolism and lipid biosynthesis.

Authors: J Caldwell; M V Marsh
Journal: Biochem Pharmacol Date: 1983-06-01 Impact factor: 5.858

4. Inhibition of prostaglandin biosynthesis by clidanac and related compounds: structural and conformational requirements for PG synthetase inhibition.

Authors: S Tamura; S Kuzuna; K Kawai
Journal: J Pharm Pharmacol Date: 1981-01 Impact factor: 3.765

5. Optical isomerization of R(-)-clidanac to the biologically active S(+)-isomer in guinea-pigs.

Authors: S Tamura; S Kuzuna; K Kawai; S Kishimoto
Journal: J Pharm Pharmacol Date: 1981-11 Impact factor: 3.765

6. Pharmacokinetic analysis of the enantiomeric inversion of chiral nonsteroidal antiinflammatory drugs.

Authors: R Mehvar; F Jamali
Journal: Pharm Res Date: 1988-02 Impact factor: 4.200

7. Stereoselective disposition of ibuprofen enantiomers in man.

Authors: E J Lee; K Williams; R Day; G Graham; D Champion
Journal: Br J Clin Pharmacol Date: 1985-05 Impact factor: 4.335

8. Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. IV. Ketoprofen disposition.

Authors: A Abas; P J Meffin
Journal: J Pharmacol Exp Ther Date: 1987-02 Impact factor: 4.030

9. Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. III. Fenoprofen disposition.

Authors: P J Hayball; P J Meffin
Journal: J Pharmacol Exp Ther Date: 1987-02 Impact factor: 4.030

10. Etodolac (1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid): a potent antiinflammatory drug. Conformation and absolute configuration of its active enantiomer.

Authors: L G Humber; C A Demerson; P Swaminathan; P H Bird
Journal: J Med Chem Date: 1986-05 Impact factor: 7.446

24 in total

Review 1. Choosing the right nonsteroidal anti-inflammatory drug for the right patient: a pharmacokinetic approach.

Authors: N M Davies; N M Skjodt
Journal: Clin Pharmacokinet Date: 2000-05 Impact factor: 6.447

Review 2. Stereoselectivity in clinical pharmacokinetics and drug development.

Authors: D B Campbell
Journal: Eur J Drug Metab Pharmacokinet Date: 1990 Apr-Jun Impact factor: 2.441

Review 3. Clinical pharmacokinetics 1990.

Authors: G R Matzke; W L St Peter
Journal: Clin Pharmacokinet Date: 1990-01 Impact factor: 6.447

Pharmacokinetics of enantiomers of chiral non-steroidal anti-inflammatory drugs.

1. Inversion of optical configuration of alpha-methylfluorene-2-acetic acid (cicloprofen) in rats and monkeys.

2. Stereoselective gas chromatographic analysis of etodolac enantiomers in human plasma and urine.

Review 3. Interrelationships between xenobiotic metabolism and lipid biosynthesis.

4. Inhibition of prostaglandin biosynthesis by clidanac and related compounds: structural and conformational requirements for PG synthetase inhibition.

5. Optical isomerization of R(-)-clidanac to the biologically active S(+)-isomer in guinea-pigs.

6. Pharmacokinetic analysis of the enantiomeric inversion of chiral nonsteroidal antiinflammatory drugs.

7. Stereoselective disposition of ibuprofen enantiomers in man.

8. Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. IV. Ketoprofen disposition.

9. Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. III. Fenoprofen disposition.

10. Etodolac (1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid): a potent antiinflammatory drug. Conformation and absolute configuration of its active enantiomer.

Review 1. Choosing the right nonsteroidal anti-inflammatory drug for the right patient: a pharmacokinetic approach.

Review 2. Stereoselectivity in clinical pharmacokinetics and drug development.

Review 3. Clinical pharmacokinetics 1990.

Review 4. Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Review 5. Preclinical and clinical development of dexketoprofen.

6. Enantiomer-specific ketorolac pharmacokinetics in young women, including pregnancy and postpartum period.

7. Disposition of ibuprofen in patients with liver cirrhosis. Stereochemical considerations.

8. Stereoselective systemic disposition of ibuprofen enantiomers in the dog.

Review 9. Clinical pharmacokinetics of drugs used in juvenile arthritis.

10. Renal handling and effects of S(+)-ibuprofen and R(-)-ibuprofen in the rat isolated perfused kidney.